Federal award
KBR WYLE SERVICES, LLC
0011
Contract
Obligated and Ceiling
- Obligated (net)
- $11,519,201.73
- Ceiling (potential value, not spending)
- $11,519,201.73
- Current value
- $11,519,201.73
- Gross positive obligations
- $11,532,100.59
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · XDBKTYM3KH19
- Owner company
- LinQuestBasis reported by USAspending: the recipient reports this company as its parent; ownership is not reviewed.
- Reported parent
- LINQUEST CORPORATION · HQBRRJBLDQ37
- Awarding agency
- Department of War · sub-agency 2100 · office W900KK
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 5999 · MISCELLANEOUS ELECTRICAL AND ELECTRONIC COMPONENTS
- Industry (NAICS)
- 334220 · RADIO AND TELEVISION BROADCASTING AND WIRELESS COMMUNICATIONS EQUIPMENT MANUFACTURING
- PIID
- 0011
- Parent vehicle (IDV PIID)
- W900KK15D0023
- Award type code
- C
- Actions
- 21 · May 26, 2016 to Aug 7, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History21
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 7, 2023 | FY2023 | 20 | C | $12,898.86 | |
| Aug 4, 2023 | FY2023 | 19 | B | −$12,898.86 | |
| Aug 1, 2023 | FY2023 | 18 | B | $50,550.58 | |
| Feb 14, 2023 | FY2023 | 17 | B | $0.00 | |
| Sep 20, 2022 | FY2022 | 16 | G | $328,437.90 | |
| Apr 11, 2022 | FY2022 | 15 | M | $0.00 | |
| Aug 6, 2021 | FY2021 | 14 | D | $0.00 | |
| Jun 23, 2021 | FY2021 | 13 | D | $1,143,879.25 | |
| Dec 11, 2020 | FY2021 | 12 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 30, 2020 | FY2020 | 11 | G | $977,715.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 30, 2020 | FY2020 | 10 | G | $972,687.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 12, 2020 | FY2020 | 9 | G | $75,324.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 5, 2019 | FY2020 | 8 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 2, 2019 | FY2019 | 7 | G | $2,631,036.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 9, 2019 | FY2019 | 6 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 1, 2019 | FY2019 | 5 | B | $240,703.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 8, 2019 | FY2019 | 4 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jan 4, 2018 | FY2018 | 3 | B | $149,986.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 6, 2017 | FY2017 | 2 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 19, 2016 | FY2016 | 1 | M | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 26, 2016 | FY2016 | 0 | — | $4,948,883.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.